Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Infections caused by species are relatively rare and primarily affect immunocompromised patients. There are few reported cases of causing empyema in patients with systemic lupus erythematosus (SLE). We present a case of a 49-year-old female patient with SLE on immunosuppressive therapy (corticosteroids and azathioprine), admitted with dyspnea and left-sided pleuritic chest pain. A diagnosis of large parapneumonic left pleural effusion was established based on blood tests, blind thoracentesis findings, and bronchoalveolar lavage results. The patient received empirical intravenous antibiotic therapy with imipenem/cilastatin and vancomycin without isolating the causative organism for 10 days. Three weeks postdischarge, the patient's left pleuritic chest pain worsened, prompting chest computed tomography that revealed multiple loculated pleural-abdominal wall fluid collections. Ultrasound-guided aspiration of these areas yielded pus cultured positive for N. The patient showed improvement following treatment with imipenem/cilastatin and trimethoprim/sulfamethoxazole. This case represents a rare manifestation of N causing pleural and abdominal wall empyema. Ultrasound-guided aspiration, targeting the loculated and encapsulated effusion, played a crucial role in confirming the diagnosis. Empirical treatment with imipenem/cilastatin combined with long-term oral trimethoprim/sulfamethoxazole was found to be effective.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11930401PMC
http://dx.doi.org/10.1016/j.radcr.2025.01.077DOI Listing

Publication Analysis

Top Keywords

systemic lupus
8
lupus erythematosus
8
pleuritic chest
8
chest pain
8
ultrasound-guided aspiration
8
treatment imipenem/cilastatin
8
ultrasound-guided thoracentesis
4
thoracentesis diagnosing
4
diagnosing -related
4
-related empyema
4

Similar Publications

Case Report: Sequential treatment with rituximab and belimumab in a pediatric patient of type 1 diabetes mellitus complicated with systemic lupus erythematosus.

Front Pediatr

August 2025

Department of Rheumatology and Immunology, Tianjin Children's Hospital (Children's Hospital, Tianjin University), Tianjin Key Laboratory of Birth Defects for Prevention and Treatment, Tianjin, China.

Type 1 diabetes mellitus (T1DM) and systemic lupus erythematosus (SLE) are both autoimmune diseases influenced by multiple genetic and environmental factors, but rarely coexist. This case describes a 13-year-old girl with early onset of T1DM who was diagnosed with SLE 12 years later, highlighting diagnostic and therapeutic challenges, particularly in distinguishing kidney involvement and management without exacerbating hyperglycemia. The patient presented with edema of the eyelids and lower limbs.

View Article and Find Full Text PDF

Neutrophilic urticarial dermatosis (NUD) is a rare condition that clinically resembles urticaria but is distinguished histopathologically. Given the overlap of clinical and histopathologic features between NUD, urticaria, and urticarial vasculitis (UV), distinguishing between these diagnoses is crucial, as their treatments differ significantly. A 47-year-old woman with systemic lupus erythematosus (SLE) presented with a mildly pruritic, burning rash for one week.

View Article and Find Full Text PDF

The coexistence of systemic lupus erythematosus (SLE) and Crohn disease (CD) is rare and presents significant diagnostic and therapeutic challenges due to overlapping clinical, radiologic, and histologic features. We present a 24-year-old woman with SLE, chronic immune thrombocytopenic purpura, and newly diagnosed CD treated with risankizumab, an interleukin-23 inhibitor approved for CD. She achieved complete clinical and radiologic remission of CD without SLE flares over 12 months.

View Article and Find Full Text PDF

[Important medical-dental interactions. Oral manifestations of systemic auto-immune diseases].

Ned Tijdschr Tandheelkd

September 2025

The Department of Oral and Maxillofacial Surgery, University Medical Center Groningen (UMCG), The Netherlands.

Systemic auto-immune diseases are relatively common. This article describes the oral manifestations of disorders that might be seen in patients with the most prevalent auto-immune diseases, specifically rheumatoid arthritis, systemic lupus erythematosus and Sjögren's disease. The article gives guidelines for dentists and other carers within the oral care system for this category of patients.

View Article and Find Full Text PDF

Pharmacological insights into gut microbiota modulation in systemic lupus erythematosus: Mechanisms, treatment strategies, and clinical implications.

J Pharmacol Exp Ther

July 2025

Department of Pharmacy Practice, Parul Institute of Pharmacy & Research, Parul University, Limda, Waghodia, Vadodara, Gujarat, India. Electronic address:

Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by widespread inflammation and immune system dysregulation. Recent research suggests that the gut microbiota may play a role in the development of SLE by modulating immune system responses, affecting cytokine production, and altering the activity of T and B cells lymphocytes. As a result, there is a growing interest in microbiota-targeted therapies, including probiotics, dietary changes, and fecal microbiota transplantation.

View Article and Find Full Text PDF